Early postoperative bleeding in polytrauma patients treated with fondaparinux: Literature review and institutional experience

Current Vascular Pharmacology

Volumn 9, Issue 1, 2011, Pages 42-47

  Tsiridis, Eleftherios ^a   Gamie, Zakareya ^a   George, Marc J ^a   Hamilton Baille, Daisy ^a   West, Robert M ^b   Giannoudis, Peter V ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

Acetabulum; Anticoagulant; Deep vein thrombosis; Enoxaparin; Fondaparinux; Fracture; Pelvis

Indexed keywords

ENOXAPARIN; FONDAPARINUX;

ACETABULUM FRACTURE; ADULT; ARTICLE; BLOOD CLOTTING DISORDER; BLOOD TRANSFUSION; CONTROLLED STUDY; DEEP VEIN THROMBOSIS; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; HIP ARTHROPLASTY; HIP FRACTURE; HUMAN; INJURY SCALE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MEDICAL LITERATURE; MULTIPLE TRAUMA; ORTHOPEDIC SURGERY; PARTIAL THROMBOPLASTIN TIME; PELVIS FRACTURE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE THROMBOSIS; PROTHROMBIN TIME; THROMBIN TIME; THROMBOCYTOPENIA; THROMBOSIS PREVENTION;

ACETABULUM; ADULT; ANTICOAGULANTS; ENOXAPARIN; FEMALE; FRACTURES, BONE; HUMANS; MALE; ORTHOPEDIC PROCEDURES; PELVIC BONES; POLYSACCHARIDES; POSTOPERATIVE HEMORRHAGE; PULMONARY EMBOLISM; VENOUS THROMBOSIS; WOUNDS AND INJURIES;

EID: 78650938989     PISSN: 15701611     EISSN: None     Source Type: Journal    
DOI: 10.2174/157016111793744670     Document Type: Article

References (25)

1. Geerts WH, Code KI, Jay RM, et al. A prospective study of venous thromboembolism after major trauma. N Engl J Med 1994; 331: 1601-1606
2. Montgomery KD, Geerts WH, Potter HG, Helfet DL. Thromboembolic complications in patients with pelvic trauma. Clin Orthop Relat Res 1996; 329: 68-87
3. Stannard JP, Singhania AK, Lopez-Ben, et al. Deep-vein thrombosis in high-energy skeletal trauma despite thromboprophylaxis. J Bone Joint Surg Br 2005; 87: 965-968
4. Agnelli G. Prevention of venous thromboembolism in surgical patients. Circulation 2004; 110: 4-12
5. Lieberman JR, Hsu WK. Prevention of venous thromboembolic disease after total hip and knee arthroplasty. J Bone Joint Surg Am 2005; 87: 2097-2112
6. Steele N, Dodenhoff RM, Ward AJ, Morse MH. Thromboprophylaxis in pelvic and acetabular trauma surgery. The role of early treatment with low-molecular-weight heparin. J Bone Joint Surg Br 2005; 87: 209-212
7. Bauer KA, Eriksson BI, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery. N Engl J Med 2001; 345: 1305-1310
8. Eriksson BI, Bauer KA, Lassen MR, Turpie AG. Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after hip-fracture surgery. N Engl J Med 2001; 345: 1298-1304
9. Lassen MR, Bauer KA, Eriksson BI, Turpie AG. Postoperative fondaparinux vs. preoperative enoxaparin for prevention of venous thromboembolism in elective hip-replacement surgery: a randomised double-blind comparison. Lancet 2002; 359: 1715-1720
10. Turpie A, Bauer K, Eriksson B, Lassen M. Efficacy and safety of fondaparinux in major orthopedic surgery according to the timing of its first administration. Thromb Haemost 2003; 90: 364-366
11. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Postoperative fondaparinux vs. postoperative enoxaparin for prevention of venous thromboembolism after elective hip-replacement surgery: a randomised double-blind trial. Lancet 2002; 359: 1721-1726
12. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Superiority of fondaparinux over enoxaparin in preventing venous thromboembolism in major orthopedic surgery using different efficacy end points. Chest 2004; 126: 501-508
13. Colwell CW, Jr., Hardwick ME. Rationale for low-molecular-weight heparin prophylaxis after total knee arthroplasty. Clin Orthop Relat Res 2006; 452: 181-185
14. Bauer KA. Fondaparinux: a new synthetic and selective inhibitor of Factor Xa. Best Pract Res Clin Haematol 2004; 17: 89-104
15. Bauer KA. New anticoagulants: anti IIa vs. anti Xa--is one better? J Thromb Thrombolysis 2006; 21: 67-72
16. Bates SM, Weitz JI. The status of new anticoagulants. Br J Haematol 2006; 134: 3-19
17. Wells PS, Anderson DR, Rodger M, et al. Derivation of a simple clinical model to categorize patients probability of pulmonary embolism: increasing the models utility with the SimpliRED D-dimer. Thromb Haemost 2000; 83: 416-420
18. Tran AH, Lee G. Fondaparinux for prevention of venous thromboembolism in major orthopedic surgery. Ann Pharmacother 2003; 37: 1632-1643
19. Barclay L. FDA Safety Changes: Prevacid NapraPAC 500, Prezista, Arixtra. In: Medscape Medical News; New York, Medscape, LLC: 2009
20. Turpie AG, Bauer KA, Eriksson BI, Lassen MR. Fondaparinux vs. enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies. Arch Intern Med 2002; 162: 1833-1840
21. Eriksson BI, Lassen MR. Duration of prophylaxis against venous thromboembolism with fondaparinux after hip fracture surgery: a multicenter, randomized, placebo-controlled, double-blind study. Arch Intern Med 2003; 163: 1337-1342
22. Oster G, Vera M. Clinical relevance of bleeding index. Arch Intern Med 2003; 163: 2794
23. Turpie A, Bauer K, Eriksson B, Lassen M. Effect on efficacy and safety of the timing of the first pentasaccharide (fondaparinux, Arixtra) administration in the prevention of venous thromboembolism (VTE) after major orthopedic surgery (abstract 119). Blood 2001; 98: 119
24. Eriksson BI, Lassen MR, Colwell CW, Jr. Efficacy of fondaparinux for thromboprophylaxis in hip fracture patients. J Arthroplasty 2004; 19: 78-81
25. Bauer KA. Fondaparinux: basic properties and efficacy and safety in venous thromboembolism prophylaxis. Am J Orthop 2002; 31: 4-10.